{"id":"gbs-trivalent-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fever"},{"rate":"null","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The GBS trivalent vaccine works by introducing inactivated influenza virus, RSV, and Hib antigens to the body, which triggers an immune response and the production of antibodies to fight these pathogens.","oneSentence":"Stimulates the immune system to produce antibodies against the influenza virus, RSV, and Hib.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:37:16.430Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza"},{"name":"RSV infection"},{"name":"Hib infection"}]},"trialDetails":[{"nctId":"NCT02690181","phase":"PHASE2","title":"Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-03-29","conditions":"Bacterial Infection Due to Streptococcus, Group B, Streptococcus Agalactiae","enrollment":80},{"nctId":"NCT02046148","phase":"PHASE2","title":"Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-03-18","conditions":"GBS Disease, Streptococcus Agalactiae","enrollment":75},{"nctId":"NCT02270944","phase":"PHASE2","title":"Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-11-20","conditions":"Infections, Streptococcal, Streptococcal Infections","enrollment":1053},{"nctId":"NCT01412801","phase":"PHASE2","title":"Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2011-09","conditions":"Streptococcal Infections, Gram-Positive Bacterial Infections, Bacterial Infections","enrollment":270},{"nctId":"NCT01446289","phase":"PHASE2","title":"Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-09","conditions":"Streptococcal Infection, Gram-positive Bacterial Infection, Bacterial Infection","enrollment":86},{"nctId":"NCT01193920","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2010-10","conditions":"Streptococcal Infections","enrollment":380}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GBS trivalent vaccine","genericName":"GBS trivalent vaccine","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stimulates the immune system to produce antibodies against the influenza virus, RSV, and Hib. Used for Influenza, RSV infection, Hib infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}